BridgeBio Pharma (BBIO) Total Debt Growth (3y) (2021 - 2026)
BridgeBio Pharma (BBIO) Total Debt Growth (3y) (2021 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Total Debt Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
6.94% |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
- |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
BridgeBio Pharma |
12.90 Bn |
11.97 Bn |
184.58 Mn |
43.54% |
| Date | Value |
|---|
| Mar 31, 2026 |
43.54% |
| Dec 31, 2025 |
9.42% |
| Sep 30, 2025 |
20.52% |
| Dec 31, 2024 |
8.17% |
| Sep 30, 2024 |
61.72% |
| Jun 30, 2024 |
61.90% |
| Mar 31, 2024 |
66.37% |
| Dec 31, 2023 |
68.16% |
| Sep 30, 2023 |
67.86% |
| Jun 30, 2023 |
67.99% |
| Mar 31, 2023 |
67.69% |
| Dec 31, 2022 |
67.45% |
| Sep 30, 2022 |
77.99% |
| Jun 30, 2022 |
77.35% |
| Dec 31, 2021 |
99.19% |
